Cargando…

Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes

Humalog Mix 75/25 insulin analog is widely used in the People’s Republic of China to treat type 2 diabetes mellitus, but the Humalog Mix 50/50 analog is not as yet widely used or assessed. The purpose of this 12-week, parallel-group, randomized, treat-to-target study was to evaluate the difference i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zafar, Mohammad Ishraq, Ai, Xinquan, Shafqat, Raja Adeel, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278736/ https://www.ncbi.nlm.nih.gov/pubmed/25565854 http://dx.doi.org/10.2147/TCRM.S75602

Ejemplares similares

Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study
por: Nishimura, Rimei, et al.
Publicado: (2010)

Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study
por: Mamza, J, et al.
Publicado: (2014)

Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System
por: Luo, Yong, et al.
Publicado: (2018)

Effects of Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity
por: Wang, Xinlei, et al.
Publicado: (2020)

Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes
por: Home, Philip, et al.
Publicado: (2018)

Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
por: Jinnouchi, Hideaki, et al.
Publicado: (2020)

Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog(®) in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
por: Miura, Junnosuke, et al.
Publicado: (2020)

Clinical characteristics and patient treatment satisfaction with Humalog U-200 in patients with type 2 diabetes mellitus: an observational study
por: Mamza, Jil, et al.
Publicado: (2019)

Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan‐Approved Humalog Insulin Lispro in Healthy Japanese Subjects
por: Shiramoto, Masanari, et al.
Publicado: (2022)

25, 50 and 75 years ago
por: Smith, Julian A.
Publicado: (2022)

25, 50 and 75 years ago
por: Smith, Julian A.
Publicado: (2022)

25, 50 & 75 years ago
por: Smith, Julian A.
Publicado: (2022)

25, 50 & 75 years ago
por: Smith, Julian A.
Publicado: (2022)

25, 50 & 75 years ago
por: Smith, Julian A.
Publicado: (2022)

25, 50 & 75 years ago
por: Smith, Julian A.
Publicado: (2022)

25, 50 & 75 years ago
por: Smith, Julian A.
Publicado: (2022)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study
por: Leohr, Jennifer, et al.
Publicado: (2020)

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial
por: Linnebjerg, Helle, et al.
Publicado: (2020)

Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog(®) in Japanese patients with type 1 diabetes
por: Shiramoto, Masanari, et al.
Publicado: (2020)

Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog(®) Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data
por: Leohr, Jennifer, et al.
Publicado: (2021)

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine
por: Buse, John B., et al.
Publicado: (2011)

50 and 75 ns operation
por: Arduini, G
Publicado: (2010)

Insulin Detemir Causes Lesser Weight Gain in Comparison to Insulin Glargine: Role on Hypothalamic NPY and Galanin
por: Zafar, Mohammad Ishraq, et al.
Publicado: (2014)

Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double‐blind meal test early‐phase study
por: Kazda, Christof, et al.
Publicado: (2021)

Ultra rapid lispro (URLi) shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early‐phase study
por: Leohr, Jennifer, et al.
Publicado: (2021)

Determination of optimum dose based of biological responses of lethal dose (LD(25, 50, 75)) and growth reduction (GR(25, 50, 75)) in ‘Yaghouti’ grape due to gamma radiation
por: Ghasemi-Soloklui, Ali Akbar, et al.
Publicado: (2023)

LHC experience with different bunch spacings in 2011 (25 , 50 & 75 ns)
por: Rumolo, G, et al.
Publicado: (2012)

4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression
por: Gao, Feng, et al.
Publicado: (2015)

4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-α and regulating the expression of insulin signal transduction proteins
por: GAO, FENG, et al.
Publicado: (2015)

Magnetism in Mixed Valence, Defect, Cubic Perovskites: BaIn(1–x)Fe(x)O(2.5+δ), x = 0.25, 0.50, and 0.75. Local and Average Structures
por: Lozano-Gorrín, Antonio D., et al.
Publicado: (2021)

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes
por: Buse, John B., et al.
Publicado: (2009)

Postprandial blood glucose response to a standard test meal in insulin-requiring patients with diabetes treated with insulin lispro mix 50 or human insulin mix 50
por: Gao, Y, et al.
Publicado: (2008)

Longitudinal parameters of the LHC beam in the SPS: 25 ns/50 ns/75 ns bunch spacing
por: Papotti, G, et al.
Publicado: (2009)

Comparability of Mixed IC(50) Data – A Statistical Analysis
por: Kalliokoski, Tuomo, et al.
Publicado: (2013)

50 and 75 ns operation in the LHC: Vacuum and Cryogenics observations
por: Arduini, G, et al.
Publicado: (2011)

The NHS Is 50: The First 25 Years
por: Godber, George
Publicado: (1998)

Ketoprofeno a 100,75 y 50 mgs. para analgesia postoperatoria
por: González Aguilar, Lorena
Publicado: (1999)

Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial
por: Li, Wei, et al.
Publicado: (2018)

Electric Double Layer in Water-Organic Mixed Solvents: Titania in 50% Ethylene Glycol
por: Kosmulski, Marek, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_81ip4tk7c7cpibjvt3i5ccsg5i